UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012161
Receipt number R000014215
Scientific Title local intraarterial fibrinolysis in central retinal arteryy occlusion
Date of disclosure of the study information 2013/10/30
Last modified on 2016/05/01 11:04:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

local intraarterial fibrinolysis in central retinal arteryy occlusion

Acronym

LIF in CRAO

Scientific Title

local intraarterial fibrinolysis in central retinal arteryy occlusion

Scientific Title:Acronym

LIF in CRAO

Region

Japan


Condition

Condition

central retinal artery occlusion

Classification by specialty

Neurology Ophthalmology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the proof of the efficacy of local intraarterial fibrinolysis in central retinal artery occlusion

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1. improvement of vision 48 hours after the treatment
2. improvement of vision 2 weeks after the treatment

Key secondary outcomes

1. improvement of angiographic visualization of optic artery after treatment
2. improvement of fundus examination after treatment
3. complication


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

local intraarterial fibrinosys using urokinase

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Aged 18 and over
2)Within 15 hours after development of symptoms
3)Visual acuity is 20/400 or loss
4)The case in which visual acuity improvement is not obtained under medical treatment (eye massage) conventionally which was performed by the time it resulted in endovascular treatment
5)The case which accepts the occlusion of clear CRA in fundus examination

Key exclusion criteria

1)improvement of visual acuity before treatment
2)the case in which the difficulty is became clear by examination before treatment for the approach to an ophthalmic artery
3)the case in which cerebral hemorrhage is diagnosed by examination before treatment
4)When a systemic bleeding disorder exists within three months
5)When consent acquisition for treatment cannot be carried out
6)The case diagnosed as angitis clinically or on examination
7)When the phenomenon remarkably being difficultty for treatment exists

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name naoshi ide

Organization

St. Marianna University School of Medicine, Yokohama City Seibu Hospital

Division name

Ophthalmology

Zip code


Address

1197-1, yasashicho, yokohama asahi-ku, kanagawa

TEL

045-366-1111

Email

n2ide@marianna-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name atsushi tsuchiya

Organization

St. Marianna University School of Medicine, Yokohama City Seibu Hospital

Division name

neurology

Zip code


Address

1197-1, yasashicho, yokohama asahi-ku, kanagawa

TEL

045-366-1111

Homepage URL


Email

a-t1@marianna-u.ac.jp


Sponsor or person

Institute

St. Marianna University School of Medicine, Yokohama City Seibu Hospital

Institute

Department

Personal name



Funding Source

Organization

St. Marianna University School of Medicine, Yokohama City Seibu Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖マリアンナ医科大学横浜市西部病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 10 Month 29 Day

Date of IRB


Anticipated trial start date

2013 Year 10 Month 29 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 03 Month 31 Day

Date trial data considered complete

2015 Year 03 Month 31 Day

Date analysis concluded

2015 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 10 Month 29 Day

Last modified on

2016 Year 05 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014215


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name